Associate Director, Digital Strategy & Data Orchestration – Digital Innovation Lilly Medicine Foundry at Eli Lilly and Company

Lebanon, Indiana, United States

Eli Lilly and Company Logo
Not SpecifiedCompensation
Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Healthcare, Pharmaceuticals, Biotechnology, ManufacturingIndustries

Requirements

  • Expertise in enterprise data management strategy, governance frameworks, architectural standards, and data policies
  • Knowledge of cutting-edge data governance structures, including data ownership models, stewardship programs, data quality standards, and master data management
  • Experience partnering with technology and automation teams to design and implement enterprise data architecture using modern data platforms, real-time integration, and cloud-native solutions
  • Proficiency in establishing data standards and metadata frameworks compliant with cGMP, FDA 21 CFR Part 11, EU Annex 11, and other regulatory requirements, while enabling analytics and AI/ML
  • Leadership skills to lead cross-functional data governance councils with representatives from PR&D, M&Q, QC, QA, and Engineering
  • Familiarity with emerging data technologies such as data fabric architectures, knowledge graphs, semantic layers, and advanced data cataloging
  • Ability to define data requirements and analytics capabilities for real-time visibility, predictive analytics, AI/ML, and data-driven decision making
  • Skills in developing data integrity controls, automated audit trails, and data lifecycle management
  • Experience driving adoption of modern data practices like DataOps, data observability, and automated data quality monitoring
  • Proven ability to build, mentor, and lead high-performing teams in data management, governance, architecture, quality, and regulatory compliance
  • Capability to establish metrics and KPIs for data quality, accessibility, and business value

Responsibilities

  • Collaboratively define and develop the enterprise data management strategy for the Medicine Foundry, establishing governance frameworks, architectural standards, and data policies that enable automated, paperless, and fully integrated operations
  • Maintain business ownership of the cutting-edge data governance structures including data ownership models, stewardship programs, data quality standards, and master data management processes that position the Foundry as a leader in pharmaceutical data excellence
  • Partner with Tech@Lilly and Automation teams to design and implement innovative enterprise data architecture leveraging modern data platforms, real-time integration, and cloud-native solutions that ensure seamless connectivity across MES, LIMS, SAP, Sample Management, and digital plant systems
  • Establish forward-thinking data standards and metadata frameworks that ensure compliance with cGMP, FDA 21 CFR Part 11, EU Annex 11, and other regulatory requirements while enabling advanced analytics and AI/ML capabilities
  • Lead cross-functional data governance council with representatives from PR&D, M&Q, QC, QA, and Engineering to align on data definitions, quality metrics, and integration requirements that support the digital thread vision
  • Champion the use of emerging data technologies, including data fabric architectures, knowledge graphs, semantic layers, and advanced data cataloging solutions to unlock maximum value from Foundry data assets
  • Define data requirements and analytics capabilities needed to support real-time operational visibility, predictive analytics, AI/ML applications, and data-driven decision making across the entire value chain
  • Develop and implement innovative data integrity controls, automated audit trails, and intelligent data lifecycle management processes that maintain regulatory compliance while enabling operational agility
  • Drive the adoption of modern data practices, including DataOps, data observability, and automated data quality monitoring to ensure the Foundry operates with world-class data excellence
  • Build, mentor, and lead a high-performing team of data management professionals who bring expertise in data governance, data architecture, data quality, and regulatory compliance
  • Establish metrics and KPIs to measure data quality, data accessibility, and business value

Skills

Data Management
Data Governance
Data Strategy
Enterprise Architecture
Data Policies
Governance Frameworks
Automated Operations
Digital Strategy
Data Orchestration

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI